ERBB2 and breast cancer: The prevalence of BM varied according to initial histological subtype of BC, with increased BM risk for ductal carcinoma, Scarff–Bloom–Richardson (SBR) grade III, ER+/HER2+, ER–/HER2+ and triple-negative (ER–, PR– and HER2–) subtypes.